ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Richard L. Kronenthal, 92, of Fair Lawn, New Jersey, died July 6, 2021.
“Richard spent most of his career at Ethicon (a division of Johnson & Johnson), where he became director of R&D. He led the successful development and commercialization of Vicryl, the first synthetic absorbable copolymer suture, for which he was awarded a Johnson Medal. Richard also played a lead role in developing other surgical materials, including the polymer used in the Jarvik-7 artificial heart. He retired from Ethicon in 1989 and became a consultant for numerous corporations, venture capital investors, and health-care institutions. He authored numerous publications and book chapters and was an inventor on 30 US patents.”—David Kronenthal, son
Most recent title: Chief scientific officer, Abyrx
Education: BS, chemistry, Brooklyn College, 1951; PhD, organic chemistry, Polytechnic Institute of New York University, 1955
Survivors: Children, David Kronenthal and Susan Geisler; three grandchildren; two great-grandchildren. Predeceased by wife, Beverly Kronenthal.
To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X